Separation of evodiamine and rutaecarpine with simulated moving bed chromatography

被引:0
|
作者
Yao C. [1 ]
Zheng Z. [1 ]
Tu Z. [1 ]
Lu Y. [1 ]
机构
[1] College of Chemistry and Chemical Engineering, Xiamen University, Xiamen
来源
Huagong Xuebao/CIESC Journal | 2021年 / 72卷 / 07期
关键词
Chromatography; Evodiamine; Optimization; Rutaecarpine; Separation; Simulated moving bed; Varicol;
D O I
10.11949/0438-1157.20201919
中图分类号
学科分类号
摘要
Using C18 as the stationary phase and methanol/water=70/30 (volume ratio) as the mobile phase, the three-zone simulated moving bed was used to separate two alkaloids, evodiamine and rutaecarpine. The isotherms of the two alkaloids were determined by frontal analysis, which can be described by linear isotherms with the Henry coefficients of 3.11 for evodiamine and 5.25 for rutaecarpine. The axial diffusion coefficient and mass-transfer coefficients of the two alkaloids were estimated by empirical equations. The operation conditions were designed by triangle theory and optimization method based on the mathematical model. Through optimization, the maximum feed flow rate was 0.55 ml∙min-1. The experimental purities of two products were both higher than 99%. By asynchronous switching, the feed flow rate was increased to 0.62 ml∙min-1 without additional investment and product purity loss. © 2021, Chemical Industry Press Co., Ltd. All right reserved.
引用
收藏
页码:3728 / 3737
页数:9
相关论文
共 38 条
  • [1] Wang Y X, Shi Y Q, Zhu J H., Study on the extraction methods of evodiamine and rutaecarpine from Evodia rutaecarpa, Chemical Research, 31, 4, pp. 359-364, (2020)
  • [2] Zhang C, Fan X, Xu X, Et al., Evodiamine induces caspase-dependent apoptosis and S phase arrest in human colon lovo cells, Anti-Cancer Drugs, 21, 8, pp. 766-776, (2010)
  • [3] Wang C, Li S, Wang M W., Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K/Akt/caspase and Fas-L/NF-κB signaling pathways and augmented by ubiquitin-proteasome inhibition, Toxicology in Vitro, 24, 3, pp. 898-904, (2010)
  • [4] Yuan S M, Gao K, Wang D M, Et al., Evodiamine improves congnitive abilities in SAMP8 and APP(swe)/PS<sub>1</sub>(ΔE9) transgenic mouse models of Alzheimer's disease, Acta Pharmacologica Sinica, 32, 3, pp. 295-302, (2011)
  • [5] Kobayashi Y, Nakano Y, Kizaki M, Et al., Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist, Planta Medica, 67, 7, pp. 628-633, (2001)
  • [6] Hung P H, Lin L C, Wang G J, Et al., Inhibitory effect of evodiamine on aldosterone release by zona glomerulosa cells in male rats, The Chinese Journal of Physiology, 44, 2, pp. 53-57, (2001)
  • [7] Lee H S, Oh W K, Choi H C, Et al., Inhibition of angiotensin Ⅱ receptor binding by quinolone alkaloids from Evodia rutaecarpa, Phytotherapy Research, 12, 3, pp. 212-214, (1998)
  • [8] Ueng Y F, Wang J J, Lin L C, Et al., Induction of cytochrome P450-dependent monooxygenase in mouse liver and kidney by rutaecarpine, an alkaloid of the herbal drug Evodia rutaecarpa, Life Sciences, 70, 2, pp. 207-217, (2001)
  • [9] Hu C P, Xiao L, Deng H W, Et al., The cardioprotection of rutaecarpine is mediated by endogenous calcitonin related-gene peptide through activation of vanilloid receptors in Guinea-pig hearts, Planta Medica, 68, 8, pp. 705-709, (2002)
  • [10] Iwata H, Tezuka Y, Kadota S, Et al., Mechanism-based inactivation of human liver microsomal CYP3A4 by rutaecarpine and limonin from Evodia fruit extract, Drug Metabolism and Pharmacokinetics, 20, 1, pp. 34-45, (2005)